53,365 Shares in Centene Corp (CNC) Acquired by MetLife Investment Advisors LLC

MetLife Investment Advisors LLC bought a new stake in Centene Corp (NYSE:CNC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 53,365 shares of the company’s stock, valued at approximately $5,383,000.

A number of other large investors have also bought and sold shares of CNC. Epoch Investment Partners Inc. increased its holdings in Centene by 298.0% in the third quarter. Epoch Investment Partners Inc. now owns 997,346 shares of the company’s stock valued at $96,513,000 after buying an additional 746,783 shares during the last quarter. BlackRock Inc. boosted its stake in Centene by 4.6% in the fourth quarter. BlackRock Inc. now owns 13,939,406 shares of the company’s stock valued at $1,406,209,000 after acquiring an additional 616,914 shares in the last quarter. Acadian Asset Management LLC boosted its stake in Centene by 68.2% in the fourth quarter. Acadian Asset Management LLC now owns 1,239,278 shares of the company’s stock valued at $125,021,000 after acquiring an additional 502,329 shares in the last quarter. AGF Investments Inc. acquired a new position in Centene in the fourth quarter valued at $49,577,000. Finally, Arrowstreet Capital Limited Partnership boosted its stake in Centene by 2,219.2% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 500,937 shares of the company’s stock valued at $50,535,000 after acquiring an additional 479,337 shares in the last quarter. 90.52% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

Several research firms have issued reports on CNC. Morgan Stanley upped their price objective on shares of Centene from $118.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, February 7th. ValuEngine upgraded shares of Centene from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Goldman Sachs began coverage on shares of Centene in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $135.00 price objective for the company. Credit Suisse Group upped their price objective on shares of Centene from $110.00 to $112.00 and gave the company a “neutral” rating in a research note on Wednesday, February 7th. Finally, Oppenheimer restated a “buy” rating and issued a $111.00 price objective on shares of Centene in a research note on Friday, December 15th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $110.28.

In other news, EVP Keith H. Williamson sold 5,000 shares of the stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $100.11, for a total transaction of $500,550.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher D. Bowers sold 4,800 shares of the stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $102.27, for a total transaction of $490,896.00. The disclosure for this sale can be found here. Insiders have sold 27,300 shares of company stock valued at $2,815,209 in the last quarter. Insiders own 3.00% of the company’s stock.

Shares of Centene stock opened at $101.47 on Friday. Centene Corp has a 12 month low of $65.30 and a 12 month high of $112.42. The firm has a market cap of $17,784.95, a PE ratio of 20.17, a PEG ratio of 0.98 and a beta of 0.76. The company has a current ratio of 0.93, a quick ratio of 0.93 and a debt-to-equity ratio of 0.68.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, February 6th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. Centene had a net margin of 1.71% and a return on equity of 13.68%. The business had revenue of $12.81 billion during the quarter, compared to the consensus estimate of $12.25 billion. During the same quarter in the prior year, the firm earned $1.19 earnings per share. The business’s quarterly revenue was up 7.5% compared to the same quarter last year. research analysts expect that Centene Corp will post 7.2 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “53,365 Shares in Centene Corp (CNC) Acquired by MetLife Investment Advisors LLC” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3299877/53365-shares-in-centene-corp-cnc-acquired-by-metlife-investment-advisors-llc.html.

About Centene

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corp (NYSE:CNC).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

IHI  & Intevac  Financial Comparison
IHI & Intevac Financial Comparison
Contrasting Jamba Juice  and Dunkin’ Brands
Contrasting Jamba Juice and Dunkin’ Brands
Hudson’s Bay  Receives Consensus Rating of “Hold” from Analysts
Hudson’s Bay Receives Consensus Rating of “Hold” from Analysts
TUI Group  Receives Consensus Recommendation of “Buy” from Analysts
TUI Group Receives Consensus Recommendation of “Buy” from Analysts
Premier Oil  Given Average Rating of “Hold” by Brokerages
Premier Oil Given Average Rating of “Hold” by Brokerages
Axovant Sciences  Getting Somewhat Positive Press Coverage, Study Finds
Axovant Sciences Getting Somewhat Positive Press Coverage, Study Finds


© 2006-2018 Ticker Report. Google+.